Stock Market & Financial Investment News

News Breaks October 29, 2012 07:39 EDT ACOR Acorda Therapeutics reschedules Q3 earnings report to Oct. 31 due to "Sandy" Acorda Therapeutics announced that, due to severe weather on the East Coast of the U.S., it will postpone its Q3 of 2012 financial results press release and conference call to Oct. 31 at 8:30 a.m. ET. News For ACOR From The Last 14 Days Check below for free stories on ACOR the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 20, 2013 07:12 EDT ACOR Acorda Therapeutics says issued additional U.S. patent for AMPYRA Subscribe for More Information May 9, 2013 10:11 EDT ACOR Acorda Therapeutics has a conference call hosted by JPMorgan Subscribe for More Information 07:05 EDT ACOR Acorda says data support initiation of current dalfampridine development program Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.